Garbi Finvest (539492)
Asset PlayScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹15.75 |
| Market Cap | ₹18.48 Cr |
| P/E Ratio | 26.29 |
| ROCE | 2.27% |
| ROE | 0.76% |
| Dividend Yield | 0% |
| Profit Growth | -87.2% |
| Debt/Equity | — |
| Sales Growth | -23.46% |
| 52-Week Range | ₹10.01 — ₹16.98 |
| Sector | Finance |
| Book Value | ₹68.42 |
Strengths
- Book value ₹68.42 vs price ₹15.75 gives a P/B of 0.23; the market is pricing only a fraction of net worth.
- Market cap ₹18 Cr is small, so a focused capital action or asset sale could unlock value.
- Price at ₹15.75 is near the high of ₹16.98 in the 52-week range, showing some improving sentiment or buying interest despite poor fundamentals.
- Latest quarter still has positive sales of ₹1 Cr, keeping the business alive as a going concern.
Concerns
- ROE of 0.76% and ROCE of 2.27% mean the underlying assets earn far less than a risk-free return.
- Sales growth -23.46% and profit growth -87.20%; latest net profit is ₹0 Cr, so earnings power has essentially disappeared.
- Piotroski F-Score of 3/9 indicates weak financial and operational health.
- No dividend yield and a P/E of 26.29 leave no current income or cheap earnings support.
AI Analysis
Reading Garbi Finvest, I am not tempted. Price ₹15.75, market cap only ₹18 Cr, and book value ₹68.42. That means I can buy ₹100 of net worth for about ₹23, a classic Graham asset bargain. But Benjamin Graham also taught that you must check whether the assets can earn their keep. Here ROE is 0.76% and ROCE is 2.27%. My money in a half-decent fixed deposit would earn more. Sales have declined 23.46%, and profit has collapsed 87.20%. The latest quarter shows sales of ₹1 Cr and net profit of ₹0 Cr. With a Piotroski score of 3/9, the financial health is weak. A P/E of 26.29 with no growth is meaningless; you are paying 26 times trailing earnings for a company whose earnings are vanishing. There is no dividend yield either, so patience is not rewarded. In an NBFC, the core asset is the loan book. If the return on that book is less than 1%, something is wrong with pricing, costs, or asset quality. The discount to book looks tempting, but it can be a value trap if book value itself is impaired or the business cannot generate profit. I would need to see management demonstrate capital allocation: improving returns, selling non-earning assets, or returning cash. Until then, this remains a possible asset play, not a compounding machine. I prefer a wonderful business at a fair price over a poor business at a low price.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer